Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc. (RGO)

Market Open
27 Jun, 06:06
443. 40
+4.1
+0.93%
- Market Cap
24.52 P/E Ratio
0% Div Yield
0 Volume
42.79 Eps
439.3
Previous Close
Day Range
443.4 443.4
Year Range
420 1,088
Want to track RGO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 33 days
Regeneron Pharmaceuticals, Inc. logo
RGO Regeneron Pharmaceuticals, Inc.
30 Jul 2025 (In 1 month)
-
Cons. EPS
-
EPS
Regeneron Pharmaceuticals, Inc. logo
RGO Regeneron Pharmaceuticals, Inc.
30 Apr 2025
-
Cons. EPS
-
EPS
Regeneron Pharmaceuticals, Inc. logo
RGO Regeneron Pharmaceuticals, Inc.
29 Apr 2025
-
Cons. EPS
-
EPS
Regeneron Pharmaceuticals, Inc. logo
RGO Regeneron Pharmaceuticals, Inc.
31 Jan 2025
-
Cons. EPS
-
EPS
Regeneron Pharmaceuticals, Inc. logo
RGO Regeneron Pharmaceuticals, Inc.
31 Oct 2024
-
Cons. EPS
-
EPS
Regeneron Pharmaceuticals, Inc. logo
RGO Regeneron Pharmaceuticals, Inc.
1 Aug 2024
-
Cons. EPS
-
EPS
Regeneron Pharmaceuticals, Inc. logo
RGO Regeneron Pharmaceuticals, Inc.
14 May 2024
-
Cons. EPS
-
EPS
Regeneron Pharmaceuticals, Inc. logo
RGO Regeneron Pharmaceuticals, Inc.
2 May 2024
-
Cons. EPS
-
EPS
Regeneron Pharmaceuticals, Inc. logo
RGO Regeneron Pharmaceuticals, Inc.
2 Feb 2024
-
Cons. EPS
-
EPS
Regeneron Pharmaceuticals, Inc. logo
RGO Regeneron Pharmaceuticals, Inc.
2 Nov 2023
-
Cons. EPS
-
EPS

RGO Earnings Reports FAQ

What is the earnings per share (EPS) for RGO?

The current EPS is 42.79.

When is the next earnings release date?

The next earnings release is expected to be on 2025-07-30, based on the RGO's typical earnings announcement schedule.